These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 33771840)

  • 21. Protective association of the ε2/ε3 heterozygote with Alzheimer's disease is strengthened by TOMM40-APOE variants in men.
    Kulminski AM; Philipp I; Loika Y; He L; Culminskaya I
    Alzheimers Dement; 2021 Nov; 17(11):1779-1787. PubMed ID: 34310032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis.
    Jiang Y; He T; Deng W; Sun P
    Clin Interv Aging; 2017; 12():1941-1949. PubMed ID: 29180857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study.
    Zou H; Luo S; Liu H; Lutz MW; Bennett DA; Plassman BL; Welsh-Bohmer KA
    J Prev Alzheimers Dis; 2023; 10(4):886-894. PubMed ID: 37874111
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Oveisgharan S; Buchman AS; Yu L; Farfel J; Hachinski V; Gaiteri C; De Jager PL; Schneider JA; Bennett DA
    Neurology; 2018 Jun; 90(24):e2127-e2134. PubMed ID: 29752306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease.
    Kennedy RE; Cutter GR; Schneider LS
    Alzheimers Dement; 2014 May; 10(3):349-59. PubMed ID: 23712001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease.
    Hostage CA; Roy Choudhury K; Doraiswamy PM; Petrella JR;
    PLoS One; 2013; 8(2):e54483. PubMed ID: 23405083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E polymorphisms in adults over 60 years of age with mild cognitive impairment and Alzheimer’s disease in different Venezuelan populations.
    Martínez S; Ochoa B; Pérez MR; Torrico F; García I; Garcia CC
    Biomedica; 2022 May; 42(Sp. 1):116-129. PubMed ID: 35866735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
    Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
    J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship Between Genetic Polymorphism and Cognitive Impairment in Patients with Acute Ischemic Stroke (APOE).
    Ma C; Wang D; Hong Z; Liu X; Zhu H; Chen L
    Altern Ther Health Med; 2024 Nov; 30(11):92-97. PubMed ID: 38401103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.
    Neu SC; Pa J; Kukull W; Beekly D; Kuzma A; Gangadharan P; Wang LS; Romero K; Arneric SP; Redolfi A; Orlandi D; Frisoni GB; Au R; Devine S; Auerbach S; Espinosa A; Boada M; Ruiz A; Johnson SC; Koscik R; Wang JJ; Hsu WC; Chen YL; Toga AW
    JAMA Neurol; 2017 Oct; 74(10):1178-1189. PubMed ID: 28846757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased CSF cortisol in AD is a function of APOE genotype.
    Peskind ER; Wilkinson CW; Petrie EC; Schellenberg GD; Raskind MA
    Neurology; 2001 Apr; 56(8):1094-8. PubMed ID: 11320185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of APOE ε2/ε3/ε4 polymorphism and cerebral infarction.
    Wang QY; Wang WJ; Wu L; Liu L; Han LZ
    J Neural Transm (Vienna); 2013 Oct; 120(10):1479-89. PubMed ID: 23571734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease.
    Langella S; Bonta K; Chen Y; Su Y; Vasquez D; Aguillon D; Acosta-Baena N; Baena AY; Garcia-Ospina G; Giraldo-Chica M; Tirado V; Muñoz C; Ríos-Romenets S; Guzman-Martínez C; Pruzin JJ; Ghisays V; Arboleda-Velasquez JF; Kosik KS; Tariot PN; Reiman EM; Lopera F; Quiroz YT
    Alzheimers Res Ther; 2024 Oct; 16(1):208. PubMed ID: 39354618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults.
    Lamar M; Yu L; Rubin LH; James BD; Barnes LL; Farfel JM; Gaiteri C; Buchman AS; Bennett DA; Schneider JA
    Alzheimers Dement; 2019 Feb; 15(2):258-266. PubMed ID: 30321502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOE ε4, Alzheimer's disease neuropathology and sleep disturbance, in individuals with and without dementia.
    Blackman J; Love S; Sinclair L; Cain R; Coulthard E
    Alzheimers Res Ther; 2022 Mar; 14(1):47. PubMed ID: 35354468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.